Results 51 to 60 of about 149,648 (111)

Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial. [PDF]

Eur Heart J Cardiovasc Pharmacother
Domei T, Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Kimura T, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Tamura T, Kawahatsu K, Hayashi F, Abe M, Serikawa T, Mori H, Kawamura T, Hagikura A, Shibata N, Ono K, Kimura T.   +23 more
europepmc   +1 more source

Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation. [PDF]

J Am Heart Assoc
Cheng YT, Lip GYH, Cheung BMY, Yiu KH, Tse HF, Chan YH.   +5 more
europepmc   +1 more source

Real-world evaluation of <i>CYP2C19</i> guided antiplatelet therapy in patients undergoing intracranial aneurysm repair. [PDF]

Pharmacogenomics
Fox LP, Tunehag KR, Nguyen A, Reed S, Shastri D, Quig N, Stouffer GA, Solander S, Lee CR.   +8 more
europepmc   +1 more source

Prasugrel Single Antiplatelet Therapy versus Aspirin and Clopidogrel Dual Antiplatelet Therapy for Flow Diverter Treatment for Cerebral Aneurysms: A Retrospective Multicenter Study. [PDF]

AJNR Am J Neuroradiol
Hohenstatt S, Saatci I, Jesser J, Çekirge HS, Koçer N, Islak C, Lücking H, DuPlessis J, Rautio R, Bendszus M, Vollherbst DF, Möhlenbruch MA.   +11 more
europepmc   +1 more source

Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care.

JAMA Netw Open
Krüger N, Krefting J, Kessler T, Schmieder R, Starnecker F, Dutsch A, Graesser C, Meyer-Lindemann U, Storz T, Pugach I, Frieß C, Chen Z, Bongiovanni D, Manea I, Dreischulte T, Offenborn F, Krase P, Sager HB, Wiebe J, Kufner S, Xhepa E, Joner M, Trenkwalder T, Gueldener U, Kastrati A, Cassese S, Schunkert H, von Scheidt M, DigiMed Bayern Consortium.   +28 more
europepmc   +1 more source

Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies. [PDF]

Clin Transl Sci
Cavallari LH, Lee CR, Franchi F, Keeley EC, Rossi JS, Thomas CD, Gong Y, McDonough CW, Starostik P, Al Saeed MJ, Been L, Kulick N, Malave J, Mulrenin IR, Nguyen AB, Terrell JN, Tillotson G, Beitelshees AL, Winterstein AG, Stouffer GA, Angiolillo DJ.   +20 more
europepmc   +1 more source

Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel. [PDF]

Clin Res Cardiol
Aytekin A, Scalamogna M, Coughlan JJ, Lahu S, Ndrepepa G, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Witzenbichler B, Hochholzer W, Sibbing D, Angiolillo DJ, Hemetsberger R, Tölg R, Valina C, Müller A, Kufner S, Liebetrau C, Xhepa E, Hapfelmeier A, Sager HB, Joner M, Richardt G, Laugwitz KL, Neumann FJ, Schunkert H, Schüpke S, Kastrati A, Cassese S.   +29 more
europepmc   +1 more source

Giant Aneurysm in the V1 Segment of Vertebral Artery: A Case Report and Literature Review. [PDF]

NMC Case Rep J
Kushino K, Mori K, Tamase A, Fukui I, Fushimi S, Nakano T, Kojima M, Yamada R, Taguchi H, Nomura M.   +9 more
europepmc   +1 more source

Impact of Society Guidelines on Trends in Use of Newer P2Y₁₂ Inhibitors for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. [PDF]

J Am Heart Assoc
Mohamed MO, Kontopantelis E, Alasnag M, Abid L, Banerjee A, Sharp ASP, Bourantas C, Sirker A, Curzen N, Mamas MA.   +9 more
europepmc   +1 more source